Sinotherapeutics Inc. (688247.SH): Hydrochloric acid Alprazolam sustained-release tablets obtained approval number from Colombia INVIMA.

date
15:37 25/05/2026
avatar
GMT Eight
Xuantai Pharmaceutical (688247.SH) announced recently that the company has received notification from the Colombian National Food and Drug Surveillance Institute (INVIMA) that their generic drug application for Extended-Release Venlafaxine Hydrochloride Tablets has been officially approved. The main component of Extended-Release Venlafaxine Hydrochloride Tablets is Venlafaxine Hydrochloride, which belongs to the amino ketone class of antidepressants. The approved indications for this drug include the treatment of severe depression and prevention of seasonal affective disorder.
Sinotherapeutics Inc. (688247.SH) announced that recently, the company has received notification from the Colombian National Food and Drug Surveillance Institute (INVIMA) that its application for a generic drug of sustained-release venlafaxine hydrochloride tablets has been officially approved. The main component of the sustained-release venlafaxine hydrochloride tablets is venlafaxine hydrochloride, which belongs to the amino ketone class of antidepressant drugs. The approved indication for this drug is the treatment of severe depression and the prevention of seasonal affective disorder. The approval of the sustained-release venlafaxine hydrochloride tablets by INVIMA in Colombia signifies that the company has obtained the qualification to market the product in the Colombian market. This is an important progress for the company in the Latin American market, which will help the company continuously expand its sales volume in the Latin American market, enrich its product portfolio, and have a positive impact on the company's long-term operations.